Clinical Trials in Rhode Island

Rhode Island is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Rhode Island and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 65 actively recruiting studies with Rhode Island sites out of 65 registered in total. The busiest research areas in Rhode Island are Ulcerative Colitis, Diabetic Peripheral Neuropathic Pain, Pulmonary Hypertension. Leading sponsors running trials in the state include Brown University, National Cancer Institute (NCI), Pfizer. By stage, Rhode Island trials break down as Phase 1 (5), Phase 2 (11), Phase 3 (19), Phase 4 (1).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Frequently Asked Questions — Clinical Trials in Rhode Island